Seet RCS et al. Stroke 2011; 42:2333-2335
Authors highlight increased risk of alteplase in warfarin patients treated at a single site, irrespective of htn or stroke etiolgy, or INR .
Authors highlight increased risk of alteplase in warfarin patients treated at a single site, irrespective of htn or stroke etiolgy, or INR .
No comments:
Post a Comment